Navigation Links
Biomet Hip Lawsuits Move Forward, as Federal Court Issues New Order Pertaining to Non-Revision Biomet Hip Replacement Claims, Bernstein Liebhard LLP Reports
Date:12/30/2013

New York, NY (PRWEB) December 30, 2013

Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) alleging injuries due to the metal-on-metal design of the Biomet M2a Magnum Hip Replacement System continue to move forward in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an Order issued on December 11, 2013, the Court is preparing to establish a Non-Revision Track for all claims filed on behalf of plaintiffs who have not undergone revision surgery of their Biomet hip replacement. The parties have been directed to submit an agreed-upon list of cases to be included on the Non-Revision Track no later than January 22, 2014. The Order states that the Court will then stay all proceedings in the non-revision cases until further notice. At that point, the Court will consider individual motions to lift stays in particular Biomet hip lawsuits. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“We are representing a number of Biomet hip lawsuit clients in claims that have been filed in this proceeding. We look forward to additional progress in the new year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal consultations to individuals who may have been injured by the Biomet M2a Magnum Hip Replacement System.

Biomet Hip Lawsuits
According to court documents, nearly 900 Biomet hip lawsuits are now pending in the proceeding underway in Indiana. These lawsuits allege that microscopic metal particles shed from the M2a Magnum hip can cause debilitating complications, including metallosis, chronic pain, and loss of mobility. In many of these claims, plaintiffs allege that they were forced to undergo revision surgery to remove and replace their Biomet hip replacement due to these types of injuries. Among other things, the complaints point out that the Biomet M2a Magnum hip was permitted to come to market via the U.S. Food & Drug Administration’s (FDA) 510 (k) clearance program, which does not require that a device be subjected to human clinical trials.

According to a safety communication issued by the FDA last January, metal-on-metal hip implants may be more likely to fail within several years of surgery than those made from other materials. Patients implanted with these types of devices have been advised to seek medical attention if they experience any symptoms that could indicate their artificial hip may be failing prematurely. The FDA has also proposed a new regulation that would no longer allow 510(k) approvals for all-metal hips. The new rules would also require the manufacturers of metal-on-metal hip implants already on the market to conduct post-safety studies of their products if they want to continue selling them.

Individuals who have suffered serious complications allegedly related to the metal-on-metal design of the Biomet M2a Magnum hip could be entitled to compensation for medical bills, lost wages, pain and suffering and more. For more information regarding the possible complications associated with metal-on-metal hip implants, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-hip-replacement/prweb11450585.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Physical Security Market (Video Surveillance, Access Control, Biometrics, Security Consulting) Worth $85.51 Billion by 2018 – New Report by MarketsandMarkets
2. Nearly 900 Cases Now Pending in Federal Biomet Hip Lawsuit Litigation; Federal Judge Sets Deadlines for Bellwether Trial Selection, Bernstein Liebhard LLP Reports
3. Judge Overseeing Federal Biomet Hip Lawsuits Won't Name Special Discovery Master, Bernstein Liebhard LLP Reports
4. Biomet Lawsuit News: Federal Court Releases New Leadership Order, Notes Rottenstein Law Group LLP
5. Biomet Hip Lawsuits Move Forward, As Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Multidistrict Litigation
6. Bilateral Biomet Hip Implants Cause Maryland Man Severe Pain, Elevated Metal Ion Levels, and Revision Surgeries, Alleges Lawsuit Filed by Parker Waichman LLP
7. Dr. Peter Bassett, Dental Implants Dentist in Tempe, AZ Introduces Biomet 3i Dental Implants for Faster, More Successful Implant Procedures
8. Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Parties’ Submission of Bellwether Trial Proposals in Federal Biomet Hip Replacement Litigation
9. Biomet Hip Lawsuit News: Rottenstein Law Group LLP Discusses Canadian M2A Magnum Class Action
10. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Filing of Biomet Hip Replacement Class Action Lawsuit in Canada
11. Biometrics must respond to human aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
Breaking Medicine Technology: